Metabolic memory underlying minimal residual disease in breast cancer

Tumor relapse from treatment‐resistant cells (minimal residual disease, MRD) underlies most breast cancer‐related deaths. Yet, the molecular characteristics defining their malignancy have largely remained elusive. Here, we integrated multi‐omics data from a tractable organoid system with a metabolic...

Descripción completa

Detalles Bibliográficos
Autores principales: Radic Shechter, Ksenija, Kafkia, Eleni, Zirngibl, Katharina, Gawrzak, Sylwia, Alladin, Ashna, Machado, Daniel, Lüchtenborg, Christian, Sévin, Daniel C, Brügger, Britta, Patil, Kiran R, Jechlinger, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8543468/
https://www.ncbi.nlm.nih.gov/pubmed/34694069
http://dx.doi.org/10.15252/msb.202010141

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8543468/
https://www.ncbi.nlm.nih.gov/pubmed/34694069
http://dx.doi.org/10.15252/msb.202010141

Ejemplares similares